Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States-Reference-Cited by-同舟云学术

Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States

Published:2018-11 Issue:2 Volume:151 Page:190-195
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Shenolikar Rahul,Durden Emily,Meyer Nicole,Lenhart Gregory,Moore Kathleen

Funder

International Business Machines Corporation

AstraZeneca

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference20 articles.

1. Therapy-related myeloid leukemia;Godley;Semin. Oncol.,2008

2. Current knowledge and future research directions in treatment-related second primacy malignancies;Morton;EJC Suppl.,2014

3. Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study;Granfeldt Østgård;J. Clin. Oncol.,2015

5. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975–2008;Morton;Blood,2013

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection and analysis of the safety profile of talazoparib based on FAERS database;Expert Opinion on Drug Safety;2024-08-17

2. Myeloid neoplasms in individuals with breast and ovarian cancer and the association with deleterious germline variants;Gynecologic Oncology;2024-08

3. Olaparib maintenance therapy for platinum‐sensitive relapsed ovarian cancer at a single institution: A retrospective study;Journal of Obstetrics and Gynaecology Research;2024-05-14

4. Therapy‐related myeloid neoplasms after treatment for ovarian cancer: A retrospective single‐center case series;Journal of Obstetrics and Gynaecology Research;2024-04-17

5. T Cell-Mediated Tumor Killing Sensitivity Gene Signature-Based Prognostic Score For Acute Myeloid Leukemia;2024-01-25